0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 61-80 of 683 Articles
JAMA Psychiatry | 
Original Investigation | 
Lee M. Hampton, MD, MSc; Matthew Daubresse, MHS; Hsien-Yen Chang, PhD; et al.
JAMA Psychiatry. 2014;71(9):1006-1014. doi:10.1001/jamapsychiatry.2014.436.
Includes: Supplemental Content

JAMA Ophthalmology | 
Observation | 
Veena Rao, MD, MSc; Eric Schneider, MD; Alan D. Proia, MD, PhD; et al.
JAMA Ophthalmol. 2014;132(9):1150-1152. doi:10.1001/jamaophthalmol.2014.1088.

JAMA Dermatology | 
Invited Commentary | 
April W. Armstrong, MD, MPH
JAMA Dermatol. 2014;150(9):963. doi:10.1001/jamadermatol.2014.1019.

JAMA Dermatology | 
Case Report/Case Series | 
Tali Garin Shkolnik, MD, PhD; Hana Feuerman, MD; Elena Didkovsky, MD; et al.
JAMA Dermatol. 2014;150(9):984-989. doi:10.1001/jamadermatol.2013.8895.

JAMA Dermatology | 
JAMA Dermatology Clinicopathological Challenge | 
Aizuri Murad, MRCS, MRCP; Anne Fortune, MRCPI, FRCPath; Fergal J. Moloney, MD, MRCPI, FACD
JAMA Dermatol. 2014;150(9):1003-1004. doi:10.1001/jamadermatol.2014.547.

JAMA Dermatology | 
Observation | 
Sarah I. Jawed, BA; Klaus Busam, MD; Xuan Wang, MD, PhD; et al.
JAMA Dermatol. 2014;150(9):1021-1023. doi:10.1001/jamadermatol.2013.10615.

JAMA Ophthalmology | 
Original Investigation | 
Michael F. Marmor, MD; Julia Hu
JAMA Ophthalmol. 2014;132(9):1105-1112. doi:10.1001/jamaophthalmol.2014.1099.
Includes: CME, Supplemental Content

JAMA Dermatology | 
Observation | 
Carola Baliu, MD; Nuria Esforzado, MD; Josep M. Campistol, MD; et al.
JAMA Dermatol. 2014;150(9):1023-1024. doi:10.1001/jamadermatol.2014.158.

JAMA | 
Viewpoint | 
Ulrike Bingel, MD, PhD; For the Placebo Competence Team
JAMA. 2014;312(7):693-694. doi:10.1001/jama.2014.8342.

JAMA | 
Review | 
Anita Kohli, MD, MS; Ashton Shaffer, BA; Amy Sherman, MD; et al.
JAMA. 2014;312(6):631-640. doi:10.1001/jama.2014.7085.
Includes: CME, Supplemental Content

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(6):591. doi:10.1001/jama.2014.9326.

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(5):477. doi:10.1001/jama.2014.9731.

JAMA | 
Original Investigation | 
Wen-Hung Chung, MD, PhD; Wan-Chun Chang, MS; Yun-Shien Lee, PhD; et al.
JAMA. 2014;312(5):525-534. doi:10.1001/jama.2014.7859.
Includes: Supplemental Content

JAMA Ophthalmology | 
Research Letter | 
Satoru Kase, MD; Toshiya Shinohara, MD; Manabu Kase, MD
JAMA Ophthalmol. 2014;132(8):1021-1022. doi:10.1001/jamaophthalmol.2014.431.

JAMA Dermatology | 
Observation | 
Bao Anh Patrick Tran, BA; Robert Egbers, MD; Lori Lowe, MD; et al.
JAMA Dermatol. 2014;150(8):903-905. doi:10.1001/jamadermatol.2013.8846.

JAMA Dermatology | 
Invited Commentary | 
Bruce E. Strober, MD, PhD
JAMA Dermatol. 2014;150(8):862-863. doi:10.1001/jamadermatol.2014.681.

JAMA Internal Medicine | 
Invited Commentary | 
Wayne B. Jonas, MD, LTC (Ret); Eric B. Schoomaker, MD, PhD, LTG (Ret)
JAMA Intern Med. 2014;174(8):1402-1403. doi:10.1001/jamainternmed.2014.2114.

JAMA Internal Medicine | 
Invited Commentary | 
David M. Shahian, MD
JAMA Intern Med. 2014;174(8):1328-1329. doi:10.1001/jamainternmed.2014.155.

JAMA Internal Medicine | 
Perspective | 
Timothy Sullivan, MD
JAMA Intern Med. 2014;174(8):1219-1220. doi:10.1001/jamainternmed.2014.2299.

JAMA Internal Medicine | 
Invited Commentary | 
Beatrice Alexandra Golomb, MD, PhD
JAMA Intern Med. 2014;174(8):1270-1272. doi:10.1001/jamainternmed.2013.14543.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Tramadol and Hypoglycemia:  One More Thing to Worry About
Lewis S. Nelson, MD; David N. Juurlink, MD, PhD